CALL FOR COMPANY PRESENTATIONS
Biotech 2005 is now accepting abstracts for company presentations as
per the topics listed.
Deadline for submission of abstracts:
March 1, 2005
Please follow the instructions listed below
- Please submit your abstract via this website - click
here for the abstract form
- Abstracts must be submitted in English
- The length of the presentation will be 15 minutes
- The abstract must be received by March 1, 2005
- Abstracts received after this date will NOT be considered
- Authors will be notified whether their presentation was accepted by
March 30, 2005.
The following details must be included when submitting your abstract:
- Full contact details of the company or presenting author who is submitting
the abstract.
- Presenter's name and title, with full affiliation details must be
provided
- Title of the presentation
- Please select one of the listed topics on the abstract form.
- Please do not include tables, charts or graphs
- Abstract text is limited to 300 words only
- Abstract should state the content of the presentation clearly
- Abstracts stating "data will be discussed in the presentation"
will NOT be accepted
If you are unable to submit abstracts via the website, please contact
the Secretariat.
ABSTRACT SELECTION AND PRESENTATION
A panel of specialists, lead by the Conference Chairperson, will review
all the abstracts.
The panel includes:
Aharon Schwartz, Conference Chairman, Teva Pharmaceuticals Ltd.
Ruth Alon, Pitango Venture Capital
Morry Blumenfeld, MediTech Advisors
Ora Dar, Matimop
Eithan Galun, Hadassah University Hospital, Jerusalem
Raffi Hofstein, Hadasit, Medical Research Services and Development
Avi Molcho, Giza Venture Capital
Zeev Zehavi, Johnson & Johnson Development Corporation
|